Opioid modulation of AMPA receptors : a new target to treat mood disorders and cognitive dysfunction
There is currently no effective treatment for the cognitive impairment and psychiatric complications, including depression, associated with the prodromal phase of the development of Huntington's disease (HD). Tianeptine is a clinically used antidepressant, with reported pro-cognitive properties...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Dundee
2019
|
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.767689 |